These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19840270)

  • 1. Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus.
    Li YY; Li YN; Ni JB; Chen CJ; Lv S; Chai SY; Wu RH; Yüce B; Storr M
    Neurogastroenterol Motil; 2010 Mar; 22(3):350-e88. PubMed ID: 19840270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents.
    Lin XH; Yuece B; Li YY; Feng YJ; Feng JY; Yu LY; Li K; Li YN; Storr M
    Neurogastroenterol Motil; 2011 Sep; 23(9):862-e342. PubMed ID: 21726355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase.
    de Filippis D; Iuvone T; d'amico A; Esposito G; Steardo L; Herman AG; Pelckmans PA; de Winter BY; de Man JG
    Neurogastroenterol Motil; 2008 Aug; 20(8):919-27. PubMed ID: 18373655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats.
    Mathison R; Ho W; Pittman QJ; Davison JS; Sharkey KA
    Br J Pharmacol; 2004 Aug; 142(8):1247-54. PubMed ID: 15249429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice.
    Storr MA; Bashashati M; Hirota C; Vemuri VK; Keenan CM; Duncan M; Lutz B; Mackie K; Makriyannis A; Macnaughton WK; Sharkey KA
    Neurogastroenterol Motil; 2010 Jul; 22(7):787-96, e223. PubMed ID: 20180825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice.
    Cluny NL; Keenan CM; Duncan M; Fox A; Lutz B; Sharkey KA
    J Pharmacol Exp Ther; 2010 Sep; 334(3):973-80. PubMed ID: 20571060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids regulate intestinal motor function and electrophysiological activity of myocytes in rodents.
    Lin X; Wang H; Li Y; Chen C; Feng Y; Fichna J
    Arch Med Res; 2015 Aug; 46(6):439-47. PubMed ID: 26254701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of cannabinoid CB1 receptors suppresses the ROS-induced hypersensitivity of rat vagal lung C-fiber afferents.
    Yeh CM; Ruan T; Lin YJ; Hsu TH
    Pulm Pharmacol Ther; 2016 Oct; 40():22-9. PubMed ID: 27328978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats.
    Duncan M; Mouihate A; Mackie K; Keenan CM; Buckley NE; Davison JS; Patel KD; Pittman QJ; Sharkey KA
    Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G78-G87. PubMed ID: 18483180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.
    Abalo R; Cabezos PA; Vera G; Fernández-Pujol R; Martín MI
    Neurogastroenterol Motil; 2010 Jun; 22(6):694-e206. PubMed ID: 20132133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways.
    Gomez O; Sanchez-Rodriguez A; Le M; Sanchez-Caro C; Molina-Holgado F; Molina-Holgado E
    Br J Pharmacol; 2011 Aug; 163(7):1520-32. PubMed ID: 21480865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
    Calik MW; Carley DW
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat.
    Abalo R; Chen C; Vera G; Fichna J; Thakur GA; López-Pérez AE; Makriyannis A; Martín-Fontelles MI; Storr M
    Neurogastroenterol Motil; 2015 Dec; 27(12):1721-35. PubMed ID: 26387676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central administrations of hemopressin and related peptides inhibit gastrointestinal motility in mice.
    Li XH; Lin ML; Wang ZL; Wang P; Tang HH; Lin YY; Li N; Fang Q; Wang R
    Neurogastroenterol Motil; 2016 Jun; 28(6):891-9. PubMed ID: 26991932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis.
    Tambaro S; Casu MA; Mastinu A; Lazzari P
    Eur J Pharmacol; 2014 Apr; 729():67-74. PubMed ID: 24561047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.
    Gkoumassi E; Dekkers BG; Dröge MJ; Elzinga CR; Schmidt M; Meurs H; Zaagsma J; Nelemans SA
    Br J Pharmacol; 2007 Aug; 151(7):1041-8. PubMed ID: 17558435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.
    Keenan CM; Storr MA; Thakur GA; Wood JT; Wager-Miller J; Straiker A; Eno MR; Nikas SP; Bashashati M; Hu H; Mackie K; Makriyannis A; Sharkey KA
    Br J Pharmacol; 2015 May; 172(9):2406-18. PubMed ID: 25572435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms.
    Michler T; Storr M; Kramer J; Ochs S; Malo A; Reu S; Göke B; Schäfer C
    Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(2):G181-92. PubMed ID: 23139224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T; Ueno S; Obara Y; Nakahata N
    J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents.
    Cluny NL; Vemuri VK; Chambers AP; Limebeer CL; Bedard H; Wood JT; Lutz B; Zimmer A; Parker LA; Makriyannis A; Sharkey KA
    Br J Pharmacol; 2010 Oct; 161(3):629-42. PubMed ID: 20880401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.